During the last session, Bioceres Crop Solutions Corp (NASDAQ:BIOX)’s traded shares were 0.33 million, with the beta value of the company hitting 0.59. At the end of the trading day, the stock’s price was $4.90, reflecting an intraday gain of 1.24% or $0.06. The 52-week high for the BIOX share is $13.18, that puts it down -168.98 from that peak though still a striking 24.9% gain since the share price plummeted to a 52-week low of $3.68. The company’s market capitalization is $307.28M, and the average intraday trading volume over the past 10 days was 0.3 million shares, and the average trade volume was 311.29K shares over the past three months.
Bioceres Crop Solutions Corp (BIOX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BIOX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.1.
Bioceres Crop Solutions Corp (NASDAQ:BIOX) trade information
Bioceres Crop Solutions Corp (BIOX) registered a 1.24% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.24% in intraday trading to $4.90, hitting a weekly high. The stock’s 5-day price performance is 12.39%, and it has moved by 16.39% in 30 days. Based on these gigs, the overall price performance for the year is -60.77%. The short interest in Bioceres Crop Solutions Corp (NASDAQ:BIOX) is 1.1 million shares and it means that shorts have 2.89 day(s) to cover.
The consensus price target of analysts on Wall Street is $13, which implies an increase of 62.31% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $13 and $13 respectively. As a result, BIOX is trading at a discount of -165.31% off the target high and -165.31% off the low.
Bioceres Crop Solutions Corp (BIOX) estimates and forecasts
In the rating firms’ projections, revenue will decrease -17.74% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 61.87M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 115.67M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 84M and 124.3M respectively. In this case, analysts expect current quarter sales to shrink by -26.35% and then drop by -6.95% in the coming quarter.
While earnings are projected to return -177.18% in 2025, the next five years will return 89.38% per annum.
BIOX Dividends
Bioceres Crop Solutions Corp is due to release its next quarterly earnings on 2025-Feb-10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Bioceres Crop Solutions Corp (NASDAQ:BIOX)’s Major holders
Bioceres Crop Solutions Corp insiders own 46.80% of total outstanding shares while institutional holders control 20.68%, with the float percentage being 38.87%. SOLEL PARTNERS LP is the largest shareholder of the company, while 62.0 institutions own stock in it. As of 2024-06-30, the company held over 4.58 million shares (or 7.292% of all shares), a total value of $51.33 million in shares.
The next largest institutional holding, with 1.96 million shares, is of FOURTH SAIL CAPITAL LP’s that is approximately 3.1239% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $21.99 million.
Also, the Mutual Funds coming in first place with the largest holdings of Bioceres Crop Solutions Corp (BIOX) shares are GLOBAL X FUNDS-Global X MSCI Argentina ETF and Unified Series Trust-BALLAST SMALL/MID CAP ETF . Data provided on Feb 28, 2025 indicates that GLOBAL X FUNDS-Global X MSCI Argentina ETF owns about 871.16 shares. This amounts to just over 1.39 percent of the company’s overall shares, with a $4.27 million market value. The same data shows that the other fund manager holds slightly less at 332.43, or about 0.53% of the stock, which is worth about $1.63 million.
